AGIO logo

Agios Pharmaceuticals, Inc. (AGIO) EBIT

annual EBIT:

-$425.74M-$34.25M(-8.75%)
December 31, 2024

Summary

  • As of today (August 25, 2025), AGIO annual earnings before interest & taxes is -$425.74 million, with the most recent change of -$34.25 million (-8.75%) on December 31, 2024.
  • During the last 3 years, AGIO annual EBIT has fallen by -$47.32 million (-12.50%).
  • AGIO annual EBIT is now -2459.90% below its all-time high of -$16.63 million, reached on December 31, 2011.

Performance

AGIO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAGIOincome statement metrics

quarterly EBIT:

-$127.06M-$20.43M(-19.16%)
June 30, 2025

Summary

  • As of today (August 25, 2025), AGIO quarterly earnings before interest & taxes is -$127.06 million, with the most recent change of -$20.43 million (-19.16%) on June 30, 2025.
  • Over the past year, AGIO quarterly EBIT has dropped by -$21.24 million (-20.07%).
  • AGIO quarterly EBIT is now -4060.60% below its all-time high of $3.21 million, reached on September 30, 2014.

Performance

AGIO quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAGIOincome statement metrics

TTM EBIT:

-$461.53M-$21.24M(-4.82%)
June 30, 2025

Summary

  • As of today (August 25, 2025), AGIO TTM earnings before interest & taxes is -$461.53 million, with the most recent change of -$21.24 million (-4.82%) on June 30, 2025.
  • Over the past year, AGIO TTM EBIT has dropped by -$56.47 million (-13.94%).
  • AGIO TTM EBIT is now -8667.72% below its all-time high of -$5.26 million, reached on March 31, 2012.

Performance

AGIO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAGIOincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

AGIO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.8%-20.1%-13.9%
3 y3 years-12.5%-30.1%-16.9%
5 y5 years-34.6%-52.6%-62.7%

AGIO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-12.5%at low-40.2%at low-23.2%at low
5 y5-year-34.6%at low-58.3%at low-79.1%at low
alltimeall time-2459.9%at low-4060.6%at low-8667.7%at low

AGIO EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$127.06M(+19.2%)
-$461.53M(+4.8%)
Mar 2025
-
-$106.63M(-14.7%)
-$440.29M(+3.4%)
Dec 2024
-$425.74M(+8.7%)
-$125.04M(+21.6%)
-$425.74M(+4.6%)
Sep 2024
-
-$102.81M(-2.8%)
-$406.98M(+0.5%)
Jun 2024
-
-$105.82M(+14.9%)
-$405.06M(+3.1%)
Mar 2024
-
-$92.07M(-13.4%)
-$392.95M(+0.4%)
Dec 2023
-$391.49M(+0.6%)
-$106.28M(+5.3%)
-$391.49M(+1.8%)
Sep 2023
-
-$100.90M(+7.7%)
-$384.38M(+2.6%)
Jun 2023
-
-$93.70M(+3.4%)
-$374.57M(-1.0%)
Mar 2023
-
-$90.61M(-8.6%)
-$378.51M(-2.7%)
Dec 2022
-$389.05M(+2.8%)
-$99.17M(+8.9%)
-$389.05M(-1.4%)
Sep 2022
-
-$91.09M(-6.7%)
-$394.70M(-0.0%)
Jun 2022
-
-$97.64M(-3.5%)
-$394.76M(+1.7%)
Mar 2022
-
-$101.14M(-3.5%)
-$388.35M(+2.6%)
Dec 2021
-$378.42M(+12.7%)
-$104.83M(+15.0%)
-$378.42M(+5.4%)
Sep 2021
-
-$91.15M(-0.1%)
-$358.92M(+3.1%)
Jun 2021
-
-$91.22M(+0.0%)
-$348.06M(+2.3%)
Mar 2021
-
-$91.22M(+6.9%)
-$340.10M(+1.2%)
Dec 2020
-$335.92M(+6.2%)
-$85.33M(+6.3%)
-$335.92M(+30.3%)
Sep 2020
-
-$80.29M(-3.6%)
-$257.73M(-9.1%)
Jun 2020
-
-$83.26M(-4.3%)
-$283.61M(-8.6%)
Mar 2020
-
-$87.03M(+1117.7%)
-$310.22M(-3.3%)
Dec 2019
-$316.27M(-8.6%)
-$7.15M(-93.3%)
-$320.67M(-18.5%)
Sep 2019
-
-$106.17M(-3.4%)
-$393.43M(+1.8%)
Jun 2019
-
-$109.87M(+12.7%)
-$386.42M(+10.6%)
Mar 2019
-
-$97.48M(+22.0%)
-$349.50M(+1.0%)
Dec 2018
-$346.03M
-$79.91M(-19.4%)
-$346.03M(-2.9%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$99.16M(+35.9%)
-$356.25M(+6.0%)
Jun 2018
-
-$72.95M(-22.4%)
-$336.11M(-3.4%)
Mar 2018
-
-$94.01M(+4.3%)
-$347.76M(+8.4%)
Dec 2017
-$320.79M(+59.6%)
-$90.13M(+14.1%)
-$320.79M(+11.4%)
Sep 2017
-
-$79.02M(-6.6%)
-$288.07M(+5.7%)
Jun 2017
-
-$84.60M(+26.2%)
-$272.57M(+11.5%)
Mar 2017
-
-$67.05M(+16.8%)
-$244.44M(+21.6%)
Dec 2016
-$200.99M(+69.3%)
-$57.41M(-9.6%)
-$200.99M(+9.0%)
Sep 2016
-
-$63.51M(+12.5%)
-$184.47M(+14.3%)
Jun 2016
-
-$56.47M(+139.3%)
-$161.44M(+17.8%)
Mar 2016
-
-$23.59M(-42.3%)
-$137.10M(+15.5%)
Dec 2015
-$118.70M(+119.3%)
-$40.90M(+1.0%)
-$118.70M(+13.6%)
Sep 2015
-
-$40.48M(+26.0%)
-$104.53M(+71.8%)
Jun 2015
-
-$32.13M(+518.5%)
-$60.85M(+29.3%)
Mar 2015
-
-$5.20M(-80.6%)
-$47.04M(-13.1%)
Dec 2014
-$54.13M(+39.2%)
-$26.73M(-933.1%)
-$54.13M(+36.5%)
Sep 2014
-
$3.21M(-117.5%)
-$39.65M(-26.5%)
Jun 2014
-
-$18.33M(+49.2%)
-$53.92M(+22.2%)
Mar 2014
-
-$12.28M(+0.3%)
-$44.12M(+13.5%)
Dec 2013
-$38.88M(+69.1%)
-$12.24M(+10.6%)
-$38.88M(+17.3%)
Sep 2013
-
-$11.07M(+29.8%)
-$33.14M(+50.2%)
Jun 2013
-
-$8.53M(+21.0%)
-$22.07M(+12.2%)
Mar 2013
-
-$7.05M(+8.5%)
-$19.67M(+10.0%)
Dec 2012
-$23.00M(+38.3%)
-$6.50M(+6.1%)
-$17.88M(+57.1%)
Jun 2012
-
-$6.12M(+16.3%)
-$11.39M(+116.3%)
Mar 2012
-
-$5.26M
-$5.26M
Dec 2011
-$16.63M
-
-

FAQ

  • What is Agios Pharmaceuticals, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Agios Pharmaceuticals, Inc.?
  • What is Agios Pharmaceuticals, Inc. annual EBIT year-on-year change?
  • What is Agios Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Agios Pharmaceuticals, Inc.?
  • What is Agios Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
  • What is Agios Pharmaceuticals, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Agios Pharmaceuticals, Inc.?
  • What is Agios Pharmaceuticals, Inc. TTM EBIT year-on-year change?

What is Agios Pharmaceuticals, Inc. annual earnings before interest & taxes?

The current annual EBIT of AGIO is -$425.74M

What is the all time high annual EBIT for Agios Pharmaceuticals, Inc.?

Agios Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$16.63M

What is Agios Pharmaceuticals, Inc. annual EBIT year-on-year change?

Over the past year, AGIO annual earnings before interest & taxes has changed by -$34.25M (-8.75%)

What is Agios Pharmaceuticals, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of AGIO is -$127.06M

What is the all time high quarterly EBIT for Agios Pharmaceuticals, Inc.?

Agios Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $3.21M

What is Agios Pharmaceuticals, Inc. quarterly EBIT year-on-year change?

Over the past year, AGIO quarterly earnings before interest & taxes has changed by -$21.24M (-20.07%)

What is Agios Pharmaceuticals, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of AGIO is -$461.53M

What is the all time high TTM EBIT for Agios Pharmaceuticals, Inc.?

Agios Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$5.26M

What is Agios Pharmaceuticals, Inc. TTM EBIT year-on-year change?

Over the past year, AGIO TTM earnings before interest & taxes has changed by -$56.47M (-13.94%)
On this page